Titre :
  • Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
Auteur : Lutz, Manfred B. ; van Cutsem, Eric ; Wagener, Theo ; Van Laethem, Jean-Luc ; Vanhoefer, Udo ; Wils, Jaques ; Gamelin, Eric ; Koehne, Claus H ; Arnaud, Jean-Pierre ; Mitry, Emmanuel ; Husseini, Fares ; Reichardt, Peter ; El-Serafi, Mustafa ; Etienne, Pierre-Luc ; Lingenfelser, Thomas ; Praet, Michel ; Genicot, Bruno ; Debois, Muriel ; Nordlinger, Bernard ; Ducreux, Michel ; European Organisation for Research and Treatment of Cancer Gastrointestinal Group
Informations sur la publication : Journal of clinical oncology, 23, 36, (page 9250-9256)
Statut de publication : Publié, 2005-12
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carcinoma -- drug therapy -- pathology
Cisplatin -- administration & dosage
Deoxycytidine -- administration & dosage -- analogs & derivatives
Disease Progression
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy -- pathology
Survival Analysis
Taxoids -- administration & dosage
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2005.02.1980
info:pii/23/36/9250
info:pmid/16361622